What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Novantrone
97%DGNews: Prostate Cancer Labeling Expanded for Novantrone
97%DGNews: Novantrone Approved by FDA for Prostate Cancer
96%DGNews: ASCO: NovantroneŽ (Mitoxantrone for Injection Concentrate) May Help in Prostate Cancer
96%DGNews: FDA Approves Novantrone (Mitoxantrone) For Worsening Forms Of Multiple Sclerosis
95%DGNews: Novantrone Helps Delay Progression Of Disability In MS Patients
95%DGNews: FDA Panel Unanimously Recommends Approval For Novantrone For Multiple Sclerosis
95%DGNews: Novantrone Offers Clinical Benefit for Advanced Prostate Cancer Patients
94%DGNews: FDA Grants Priority Review To Novantrone For MS
94%DGNews: AAN MEETING: Novatrone Reduces MS Attacks, Delays Disability Progression
94%DGNews: Prostate Cancer Study Shows Combination Therapy With Novantrone Is Cost-Effective
91%DGNews: New Education Program For Men Facing Late-Stage Prostate Cancer
88%DGNews: Safety and Tolerability of Mitoxantrone for Worsening Multiple Sclerosis Appears Stable in Long Term: Presented at ECTRIMS
86%DGNews: Mitoxantrone Can Extend Time to Disease Progression in Worsening Multiple Sclerosis: Presented at AAN
85%DGNews: Real-Life Mitoxantrone (Novantrone) Study Confirms Efficacy, Safety With Known Risk of Malignancy: Presented at ECTRIMS
85%DGNews: ICACT: Hormone-Refractory Prostate Cancer Responds to Combination of Vinorelbine, Mitoxantrone, and Prednisone
82%DGNews: Guide to Pain Management Aims to Empower Prostate Cancer Patients
82%DGNews: Immunex Receives FDA Clearance for Etoposide Chemotherapy Agent
80%DGNews: DG DISPATCH - ASTRO: Method Of Treatment Affects Hodgkin's Disease Progression
79%DGNews: MS Patients Not Getting Drugs to Slow Disease Progression, Research Shows
79%DGNews: AAN: Double-Drug Therapy, Mitoxantrone/Interferon beta-1b, Shows Benefit in Multiple Sclerosis
79%DGNews: Incel Enhances Efficacy Of Chemotherapy In Prostate Cancer Patients
78%DGNews: Experimental Drug Exhibits Marked Anti-Tumour Activity
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.